心肌梗死后死亡率的进一步降低。
Further reduction in mortality following myocardial infarction.
作者信息
Abhyankar Brihad
机构信息
Cardiology Unit, Solvay Healthcare Ltd, Southampton SO18 3JD.
出版信息
Hosp Med. 2002 Oct;63(10):610-4. doi: 10.12968/hosp.2002.63.10.1933.
Abstract
Omacor is a new omega-3 fatty acid product that is licensed for secondary prevention post-myocardial infarction. It confers an additional 20% reduction in all-cause mortality, based on the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico prevenzione (GISSI-P) study data. The GISSI-P results are compared with other trials of secondary prevention.
摘要
奥米加-3脂肪酸乙酯是一种新型的ω-3脂肪酸产品，已获许可用于心肌梗死后的二级预防。根据意大利心肌梗死存活研究预防组（GISSI-P）的研究数据，它可使全因死亡率额外降低20%。将GISSI-P的结果与其他二级预防试验进行了比较。
Zotero 插件